http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103800414-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cda0c56c9c8f794ece9b0364c66693d6 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L2-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2014-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5996bdbe573c1009bd596bdb80f971dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b519e1dc243b9eaa2c27d61bab9451e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bae063182d1242870e7e814806b60d9d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_668c283bae935371219b04eedccc2ceb |
| publicationDate | 2014-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103800414-A |
| titleOfInvention | Alpha-glycosidase inhibitor and application thereof |
| abstract | The invention relates to an orally-taken alpha-glycosidase inhibitor for treating diabetes and diabetic gastroparesis. The composition comprises at least one of the alpha-glycosidase inhibitor and a rhizoma atractylodis extractive at a ratio of (1:1)-(1:10) in parts by weight, and preferably the ratio is 1:3. Through clinical and pharmacological serendipitous discoveries, the composition provided by the invention has multiple effects of inhibiting and reducing postprandial blood sugar through glycosidase, enhancing gastric emptying, helping to improve infection of helicobacter pylori and the like. When the composition disclosed by the invention is designed to be an oral chewable tablet, the rhizoma atractylodis and mulberry chewable tablet can partially act on the oral cavity to remove the helicobacter pylori from the oral cavity and is helpful for cutting off the in-vivo reinfection way of the helicobacter pylori so as to realize the aim of radical treatment on the helicobacter pylori. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2674447-C1 |
| priorityDate | 2014-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 175.